Skip to main navigation Skip to search Skip to main content

Augmentation therapy is disease modifying in alpha-1 antitrypsin deficiency (AATD). Interim analysis of the RAPID Extension Study

Kenneth Chapman, Jonathan Burdon, Eeva Piitulainen, Robert Sandhaus, Niels Seersholm, James Stocks, Gerard McElvaney

Original languageEnglish
Publication date2014
Publication statusPublished - 2014
EventATS San Diego - San Diego, United States
Duration: 15 May 201420 May 2014

Conference

ConferenceATS San Diego
Country/TerritoryUnited States
CitySan Diego
Period15/05/201420/05/2014

Cite this